Back

The differential effects of antihypertensive drugs on central blood pressure: nebivolol versus telmisartan (ATD-CBP)

28 August 2022 (14:15 - 14:45)
Organised by:
Congress Presentation Part of: Hypertension - Treatment from pharmacotherapy to device and intervention Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Assistant Professor Subin Lim

Ewha Womans University, Seoul (Korea (Republic of))

3 More presentations in this session

Presentation thumbnail
Device and non-device-guided slow breathing to reduce blood pressure in hypertensive patients: a systematic review and meta-analysis.
Doctor K. De Freitas Goncalves (Ribeirao Preto, BR)
Abstract Slides
Presentation thumbnail
Long-term antihypertensive effect of renal denervation in resistant hypertension: three years follow-up
Doctor A. Moiseeva (Chisinau, MD)
Abstract Slides
Presentation thumbnail
Spontaneous, independent, single-center renal denervation registry of a resistant hypertension multidisciplinary team
Doctor S. Fezzi (Verona, IT)
Abstract Slides

Access the full session

Session thumbnail
Hypertension - Treatment from pharmacotherapy to device and intervention

The Event

Event poster

ESC Congress 2022

28 August 2022 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Blood pressure effect of semaglutide in patients with hypertension: an individual patient data analysis of randomised controlled trials
thumbnail
Congress Presentation
Central Blood Pressure predicts the future cardiovascular risk better than peripheral Blood Pressure: the northern shanghai study
thumbnail
Congress Presentation
The effects of chronic cannabidiol dosing on cardiovascular parameters in primary hypertension: A summary of findings from a randomized controlled trial

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources